Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study
- 14 July 2016
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 23 (9), 1482-1486
- https://doi.org/10.1111/ene.13102
Abstract
The clinical predictors of health-related quality of life (HRQoL) in multiple sclerosis (MS) have mainly been studied in patients with long-standing disease. The objective of this study was to investigate the longitudinal association among HRQoL and clinical characteristics in early MS. Relapsing MS patients within 12 months of clinical onset were enrolled in a neuroprotection trial of riluzole versus placebo as an add-on to weekly interferon with up to 36 months of follow-up. Serial clinical measures included Short Form-36 (SF-36) as the measure of HRQoL, MS Functional Composite (as a measure of disability), Modified Fatigue Impact Scale, Patient Health Questionnaire-9 (as a measure of depression) and a cognitive battery. Multivariable linear regression analyses assessed cross-sectional associations. Mixed model regressions with mutual adjustments were used to assess the longitudinal association of HRQoL components and clinical, cognitive and demographic variables. Forty-three patients were enrolled within 7.5 ± 4.9 months of clinical onset (72% female, mean age 36 years). The baseline severity of fatigue and depression predicted subsequent changes in SF-36 Physical Component Summary (PCS) (P values of 0.001 and 0.021, respectively). In longitudinal analyses, changes in disability and depression were associated with changes in SF-36 PCS (P values of 0.002 and 0.009, respectively), whereas changes in cognitive function and fatigue were associated with changes in SF-36 Mental Component Summary (P values of 0.037 and 0.001, respectively). A 1-unit increase in MS Functional Composite was associated with a 7.1-point increase in SF-36 PCS (95% CI, 2.6-11.6). Fatigue, depression, cognition and disability are independently associated with HRQoL in early MS.Keywords
Funding Information
- National Multiple Sclerosis Society (RG3932-A-2)
This publication has 21 references indexed in Scilit:
- Disease-Related Determinants of Quality of Life 10 Years After Clinically Isolated SyndromeInternational Journal of MS Care, 2015
- A randomized controlled phase II trial of riluzole in early multiple sclerosisAnnals of Clinical and Translational Neurology, 2014
- Assessment of mood: Guides for cliniciansJournal of Psychosomatic Research, 2010
- Pain and Quality of Life in the Early Stages After Multiple Sclerosis DiagnosisThe Clinical Journal of Pain, 2009
- Fatigue et sclérose en plaquesAnnales de Réadaptation et de Médecine Physique, 2006
- Fatigue and multiple sclerosisAnnales de Réadaptation et de Médecine Physique, 2006
- Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior changeJournal of the Neurological Sciences, 2005
- Quality of life in patients with multiple sclerosis: The impact of fatigue and depressionJournal of the Neurological Sciences, 2002
- Minimal Neuropsychological Assessment of MS Patients: A Consensus ApproachThe Clinical Neuropsychologist, 2002
- Quality of Life in Multiple SclerosisArchives of Neurology, 1992